These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 23105224)
21. The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. Couser WG; Johnson RJ; Young BA; Yeh CG; Toth CA; Rudolph AR J Am Soc Nephrol; 1995 May; 5(11):1888-94. PubMed ID: 7620086 [TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effects of the SCR1-3 functional domain of CR1 on acute cerebral ischemia and reperfusion injury in rats. Yang S; Wang X; Zhang X; Lu Y; Wang Z Neurol Res; 2013 Nov; 35(9):976-83. PubMed ID: 23815859 [TBL] [Abstract][Full Text] [Related]
34. Genetic and structural polymorphism of complement receptor 1 in normal Indian subjects. Katyal M; Sivasankar B; Ayub S; Das N Immunol Lett; 2003 Oct; 89(2-3):93-8. PubMed ID: 14556965 [TBL] [Abstract][Full Text] [Related]
35. Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion. Chávez-Cartaya RE; DeSola GP; Wright L; Jamieson NV; White DJ Transplantation; 1995 Apr; 59(7):1047-52. PubMed ID: 7709442 [TBL] [Abstract][Full Text] [Related]
36. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis. Himmelfarb J; McMonagle E; Holbrook D; Toth C J Lab Clin Med; 1995 Oct; 126(4):392-400. PubMed ID: 7561449 [TBL] [Abstract][Full Text] [Related]
37. The effect of soluble complement receptor 1 (sCR1) and human thyroid antibodies on the course of experimental autoimmune thyroiditis in rats. Metcalfe RA; McIntosh RS; Morgan BP; Levin JL; Weetman AP Autoimmunity; 1996; 23(1):1-8. PubMed ID: 8871757 [TBL] [Abstract][Full Text] [Related]
38. Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function. Pierre AF; Xavier AM; Liu M; Cassivi SD; Lindsay TF; Marsh HC; Slutsky AS; Keshavjee SH Transplantation; 1998 Sep; 66(6):723-32. PubMed ID: 9771835 [TBL] [Abstract][Full Text] [Related]
39. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Pratt JR; Hibbs MJ; Laver AJ; Smith RA; Sacks SH Am J Pathol; 1996 Dec; 149(6):2055-66. PubMed ID: 8952538 [TBL] [Abstract][Full Text] [Related]
40. Extended in vivo half-life of human soluble complement receptor type 1 fused to a serum albumin-binding receptor. Makrides SC; Nygren PA; Andrews B; Ford PJ; Evans KS; Hayman EG; Adari H; Uhlén M; Toth CA J Pharmacol Exp Ther; 1996 Apr; 277(1):534-42. PubMed ID: 8613964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]